TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2019

PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen

Hsuan-Ming Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.